IGF1R and cancer: As a TGF-β- and IGF-responsive gene, SNCG is more frequently overexpressed in advanced cancers and involved in the stabilization or activation of some oncogenes such as IGF-IR and Akt, which have critical roles in tumorigenesis and drug resistance 2, 28, 30, 31.